The effect of infliximab on antiviral antibody profiles in patients with rheumatoid arthritis

Rheumatology International

Volumn 30, Issue 3, 2010, Pages 325-329

  Kaufman, Ilana ^a   Moscovici, Yolanda Braun ^b   Abudi, Yair ^a   Sofer, Denit ^a   Mendelson, Ella ^a   Balbir Gurman, Alexandra ^b   Caspi, Dan ^a   Elkayam, Ori ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Infliximab; Measles; Poliomyelitis; Rheumatoid arthritis; Rubella

Indexed keywords

INFLIXIMAB; METHOTREXATE; PREDNISONE; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MEASLES; POLIOMYELITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RUBELLA; SEROTYPE; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS STRAIN;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG INTERACTIONS; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOSUPPRESSION; MALE; MEASLES; METHOTREXATE; MIDDLE AGED; POLIOMYELITIS; PREDNISONE; PROSPECTIVE STUDIES; RUBELLA; VIRUS DISEASES; VIRUSES;

EID: 73649133656     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0959-7     Document Type: Article

References (15)

1. T Gluck U Muller-Ladner 2008 Vaccination in patients with chronic rheumatic or autoimmune diseases Clin Infect Dis 46 9 1459 1465 10.1086/587063 10.1086/587063 1:STN:280:DC%2BD1c3lvFertg%3D%3D 18419456 (Pubitemid 351589953)
2. IJ Amanna NE Carlson MK Slifka 2007 Duration of humoral immunity to common viral and vaccine antigens N Engl J Med 357 1903 1915 10.1056/NEJMoa066092 10.1056/NEJMoa066092 1:CAS:528:DC%2BD2sXht1ymtbjI 17989383 (Pubitemid 350074686)
3. FC Arnett SM Edworthy DA Bloch 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 10.1002/art.1780310302 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 3358796
4. R Ravikumar J Anolik J Looney 2007 Vaccine response in patients with rheumatoid arthritis Curr Rheumatol Rep 9 407 415 10.1007/s11926-007-0065-3 10.1007/s11926-007-0065-3 17915097 (Pubitemid 47597062)
5. Salliot C, Dougados M, Gossec L (2008) Risk of serious infection during rituximab, abatacept and anakinra therapies for rheumatoid arthritis: meta-analysis of randomized placebo-controlled trials. Ann Rheum Dis (Jan):18
6. D Reinhardt K Houliara A Pekrun M Lakomek B Krone 2003 Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer Scand J Infect Dis 35 11-12 851 877 10.1080/00365540310016600 10.1080/00365540310016600 14723361 (Pubitemid 38028922)
7. I Fomin D Caspi V Levy N Varsano Y Shalev D Paran, et al. 2006 Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF-alpha blockers Ann Rheum Dis 65 191 194 10.1136/ard.2005.036434 10.1136/ard.2005.036434 1:CAS:528:DC%2BD28XhsFeitL0%3D 16014674 (Pubitemid 43131992)
8. T Kubota T Nii T Nanki H Kohsaka M Harigai Y Komano, et al. 2007 Anti-tumor necrosis factor does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis Mod Rheumatol 17 6 531 533 10.1007/s10165-007-0632-5 10.1007/s10165-007-0632-5 18084712
9. Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, RimmelzwaanGF, Kroon FP (2008) The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 67(5):713-716
10. O Elkayam D Caspi T Reitblatt D Charboneau JB Rubins 2004 The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis Semin Arthritis Rheum 33 283 288 10.1053/j.semarthrit.2003.10.003 10.1053/j.semarthrit.2003.10. 003 1:CAS:528:DC%2BD2cXhtVOksL8%3D 14978666 (Pubitemid 38280827)
11. MC Kapetanovic T Saxne A Sjoholm, et al. 2006 Influence of methotrexate, TNF blockers, and prednisone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis Rheumatology 45 106 111 10.1093/rheumatology/kei193 1:CAS:528:DC%2BD2MXhtlagtbjP 16287919 (Pubitemid 43033885)
12. J O'Dell J Gilg W Palmer L Truedsson G Jönsson P Geborek 1996 Pneumococcal vaccine in rheumatoid arthritis: decreased response while taking methotrexate J Clin Rheumatol 2 59 63 10.1097/00124743-199604000-00001 19078031
13. S Visvanathan GF Keenan DG Baker AI Levinson CL Wagner 2005 Responses to the pneumococcal vaccine in patients with early rheumatoid arthritis Ann Rheum Dis 64 Suppl III 422
14. J Kaine A Kivitz C Birbara AY Luo 2007 Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab J Rheumatol 34 2 272 279 1:CAS:528:DC%2BD2sXjtFCnsbk%3D 17304653
15. G Cambridge W Stohl MJ Leandro TS Migone DM Hilbert JC Edwards 2006 Circulating level of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse Arthritis Rheum 54 3 723 732 10.1002/art.21650 10.1002/art.21650 1:CAS:528:DC%2BD28XjtV2ls70%3D 16508933